Live Breaking News & Updates on Ultima Genomics|Page 10
Stay updated with breaking news from Ultima genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At ENDO 2022, Ascendis will share Phase II and III data showing clinical efficacy for its investigational product candidate for hypoparathyroidism. For this and more, see inside. ....
Proof of concept data show potential to combine the Olink® Explore assay with readout on Ultima Genomics’ sequencing platform for high-throughput proteomics applications Olink continues. | June 8, 2022 ....